Domov › Metastatická rakovina › Missouri › Kansas City
Klinické štúdie Metastatická rakovina v meste Kansas City, MO
15 štúdií pre Metastatická rakovina hľadá účastníkov v zariadeniach v meste Kansas City a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Prebieha náborFáza 1
- St. Lukes Hospital of Kansas City, Kansas City
A Study of ASP3082 in Adults With Advanced Solid Tumors
Prebieha náborFáza 1
- University of Kansas Medical Center, Westwood · 5 míľ odtiaľ
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Prebieha náborFáza 1
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 míľ odtiaľ
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- University of Kansas Medical Center, Westwood · 5 míľ odtiaľ
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Prebieha náborFáza 2/3
- Premier Imaging, Kansas City
- St. Joseph Medical Center, Kansas City
- MidAmerica Cancer Care - American Oncology Partners, Kansas City
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Prebieha náborFáza 1
- The University of Kansas Medical Center, Westwood · 5 míľ odtiaľ
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Prebieha náborFáza 3
- HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Prebieha náborFáza 3
- Saint Luke's Cancer Institute, Kansas City
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- The University of Kansas Cancer Center - Westwood, Westwood · 5 míľ odtiaľ
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Prebieha náborFáza 1/2
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 míľ odtiaľ
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Prebieha náborFáza 3
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Cancer Center, Westwood · 5 míľ odtiaľ
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Prebieha náborFáza 3
- Saint Luke's Cancer Institute, Kansas City
- The University of Kansas Cancer Center, Westwood · 5 míľ odtiaľ
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Prebieha náborFáza 2/3
- MidAmerica Cancer Care, Kansas City
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Prebieha náborFáza 3
- University of Kansas Cancer Center, Westwood · 5 míľ odtiaľ
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Kansas City
Štúdie Metastatická rakovina v iných mestách
- Houston, TX104 štúdií
- New York City, NY93 štúdií
- Nashville, TN70 štúdií
- Boston, MA63 štúdií
- Los Angeles, CA57 štúdií
- St. Louis, MO54 štúdií
- Arlington, VA53 štúdií
- Philadelphia, PA46 štúdií
- Chicago, IL45 štúdií
- San Antonio, TX44 štúdií
- Washington, DC43 štúdií
- Dallas, TX42 štúdií
Iné štúdie v Kansas City
- Rakovina prsníka34 štúdií
- Nemalobunkový karcinóm pľúc31 štúdií
- Srdcové zlyhanie25 štúdií
- Rakovina (všetky typy)21 štúdií
- Rakovina pľúc19 štúdií
- Kolorektálny karcinóm16 štúdií
- Akútna myeloidná leukémia15 štúdií
- Rakovina prostaty14 štúdií
- Rakovina vaječníkov11 štúdií
- Obézita11 štúdií
- Diabetes mellitus 2. typu11 štúdií
- Kardiovaskulárne ochorenia11 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.